Skip to content

Ascentage Pharma

US · AAPG #3045 by market cap Listed 2025
14.94 -1.15 -7.15%
Live - 5344 symbols - heartbeat 240s ago · 2026-10-08 08:38
Pre-market 14.69 -1.67%
After-hours 14.94 0.00%
Overnight 14.70 -1.61%
Market cap
1.40B
P/B
16.81
EPS
-1.99
Reader sentiment Are you bullish or bearish on AAPG?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2025/12/4
  • Oppenheimer Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/8/21
  • Rating change
    Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $51
    Market Newswire · 2026/3/27
  • B. Riley Securities Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/9/2
  • Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)
    TipRanks · 2026/8/21
  • Rating change
    BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2025/11/10
  • Rating change
    Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $22.34
    Market Newswire · 2026/4/24
  • BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/8/21
  • Rating change
    J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating
    Market Newswire · 2025/8/22
  • Rating change
    J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $46
    Market Newswire · 2026/4/16
  • Rating change
    Lucid Capital Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2025/12/15
  • Rating change
    Piper Sandler Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
    Market Newswire · 2025/11/5
  • Rating change
    Deutsche Bank Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $40
    Market Newswire · 2026/4/24
  • Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating
    Market Newswire · 2026/8/21
  • Rating change
    BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
    Market Newswire · 2026/3/12
  • Rating change
    B. Riley Securities Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/6/10
  • Rating change
    Piper Sandler Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/6/1
  • Rating change
    J.P. Morgan Initiates Ascentage Pharma(AAPG.US) With Buy Rating
    Market Newswire · 2025/7/28
  • Rating change
    Oppenheimer Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/6/15
  • Rating change
    J.P. Morgan Sticks to Their Buy Rating for Ascentage Pharma Group International Unsponsored ADR (AAPG)
    TipRanks · 2025/8/22

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:38:13 · For reference only, not investment advice and not tailored to your situation.